当前位置:首页 >财报库 > 报告详情

西维斯健康CVS Health(CVS)2025年第三季财报电话会议纪要「NYSE」(英文版)(19页).pdf

上传人: 1****1 编号:999496 2025-12-24 19页 298.07KB

下载:

1、 Corrected Transcript 1-877-FACTSET Total Pages:19 Copyright 2001-2025 FactSet CallStreet,LLC 29-Oct-2025 CVS Health Corp.(CVS)Q3 2025 Earnings Call CVS Health Corp.(CVS)Q3 2025 Earnings Call Corrected Transcript 29-Oct-2025 1-877-FACTSET 2 Copyright 2001-2025 FactSet CallStreet,LLC CORPORATE PARTIC

2、IPANTS Laurence F.McGrath Executive Vice President,Chief Strategy Officer and Chief Strategic Advisor to the CEO,CVS Health Corp.J.David Joyner President,Chief Executive Officer&Director,CVS Health Corp.Brian O.Newman Executive Vice President&Chief Financial Officer,CVS Health Corp.Prem S.Shah Execu

3、tive Vice President&Group President,CVS Health Corp.Steven H.Nelson Executive Vice President and President,Aetna,CVS Health Corp.OTHER PARTICIPANTS Lisa C.Gill Analyst,JPMorgan Securities LLC Justin Lake Analyst,Wolfe Research LLC Elizabeth Anderson Analyst,Evercore ISI Stephen Baxter Analyst,Wells

4、Fargo Securities LLC Michael Cherny Analyst,Leerink Partners LLC Eric Percher Analyst,Nephron Research LLC Andrew Mok Analyst,Barclays Capital,Inc.George Hill Analyst,Deutsche Bank Securities,Inc.Kevin Caliendo Analyst,UBS Securities LLC CVS Health Corp.(CVS)Q3 2025 Earnings Call Corrected Transcrip

5、t 29-Oct-2025 1-877-FACTSET 3 Copyright 2001-2025 FactSet CallStreet,LLC MANAGEMENT DISCUSSION SECTION Operator:Hello,and welcome to CVS Healths Third Quarter 2025 Earnings Call.We ask that you please hold all questions until the end of the prepared remarks,at which time you will be given instructio

6、ns for the question-and-answer session.As a reminder,this conference is being recorded today.If you have any objections,please disconnect at this time.I would now like to pass the call to Larry McGrath,Chief Strategy Officer.Larry,please proceed.Laurence F.McGrath Executive Vice President,Chief Stra

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
根据文章内容,以下是关键点的概括: 1. CVS Health在2025年第三季度实现了调整后营业收入350亿美元,调整后每股收益1.60美元,连续第三个季度上调全年调整后每股收益预期至6.55-6.65美元。 2. 医疗福利业务调整后营业利润预计为27.2亿美元,医疗福利比率预计为91%。 3. 医疗服务业务调整后营业利润预计为71亿美元,受到药品客户定价改善影响。 4. 药房及消费者健康业务调整后营业利润预计为59.5亿美元,得益于处方量增长。 5. 2026年,预计医疗福利业务利润率将进一步提高,医疗服务业务将实现低个位数增长,药房及消费者健康业务将延续增长势头。 6. 2026年调整后每股收益预计将实现中双位数增长。
业绩亮眼,未来展望如何?" TrueCost模式如何引领药价透明化?" PCW业务逆势增长,秘诀何在?"
客服
商务合作
小程序
服务号
折叠